Suppr超能文献

内源性大麻素 2-花生四烯酰甘油介导 D1 和 D2 受体协同增强大鼠伏隔核核心神经元放电。

The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing.

机构信息

Ernest Gallo Clinic and Research Center, University of California, San Francisco, Department of Neurology, 5858 Horton Street, Suite 200, Emeryville, CA 94608, USA.

出版信息

Neuroscience. 2011 Oct 13;193:21-33. doi: 10.1016/j.neuroscience.2011.07.055. Epub 2011 Jul 27.

Abstract

Many motivated and addiction-related behaviors are sustained by activity of both dopamine D1- and D2-type receptors (D1Rs and D2Rs) as well as CB1 receptors (CB1Rs) in the nucleus accumbens (NAc). Here, we use in vitro whole-cell patch-clamp electrophysiology to describe an endocannabinoid (eCB)-dopamine receptor interaction in adult rat NAc core neurons. D1R and D2R agonists in combination enhanced firing, with no effect of a D1R or D2R agonist alone. This D1R+D2R-mediated firing increase required CB1Rs, since it was prevented by the CB1R antagonists AM251 and Rimonabant. The D1R+D2R firing increase also required phospholipase C (PLC), the major synthesis pathway for the eCB 2-arachidonoylglycerol (2-AG) and one of several pathways for anandamide. Further, inhibition of 2-AG hydrolysis with the monoglyceride lipase (MGL) inhibitor JZL184 allowed subthreshold levels of D1R+D2R receptor agonists to enhance firing, while inhibition of anandamide hydrolysis with the fatty acid amide hydrolase (FAAH) inhibitors URB597 or AM3506 did not. Filling the postsynaptic neuron with 2-AG enabled subthreshold D1R+D2R agonists to increase firing, and the 2AG+D1R+D2R increase in firing was prevented by a CB1R antagonist. Also, the metabotropic glutamate receptor 5 (mGluR5) blocker MPEP prevented the ability of JZL184 to promote subthreshold D1R+D2R enhancement of firing, while the 2-AG+D1R+D2R increase in firing was not prevented by the mGluR5 blocker, suggesting that mGluR5s acted upstream of 2-AG production. Thus, our results taken together are consistent with the hypothesis that NAc core eCBs mediate dopamine receptor (DAR) enhancement of firing, perhaps providing a cellular mechanism underlying the central role of NAc core D1Rs, D2Rs, CB1Rs, and mGluR5s during many drug-seeking behaviors.

摘要

许多动机和成瘾相关的行为是由多巴胺 D1 型和 D2 型受体(D1Rs 和 D2Rs)以及大麻素 CB1 受体(CB1Rs)在伏隔核(NAc)中的活性维持的。在这里,我们使用体外全细胞膜片钳电生理学技术来描述成年大鼠 NAc 核心神经元中的内源性大麻素(eCB)-多巴胺受体相互作用。D1R 和 D2R 激动剂联合增强了放电,而单独使用 D1R 或 D2R 激动剂则没有效果。这种 D1R+D2R 介导的放电增加需要 CB1Rs,因为它被 CB1R 拮抗剂 AM251 和 Rimonabant 所阻止。D1R+D2R 放电增加也需要磷脂酶 C(PLC),PLC 是内源性大麻素 2-花生四烯酸甘油(2-AG)的主要合成途径之一,也是大麻酰胺的几种合成途径之一。此外,用单酰基甘油脂肪酶(MGL)抑制剂 JZL184 抑制 2-AG 水解允许亚阈值水平的 D1R+D2R 受体激动剂增强放电,而用脂肪酸酰胺水解酶(FAAH)抑制剂 URB597 或 AM3506 抑制大麻酰胺水解则不能。将 2-AG 填充到突触后神经元中可以使亚阈值 D1R+D2R 激动剂增加放电,而 CB1R 拮抗剂则阻止了 2AG+D1R+D2R 对放电的增加。此外,代谢型谷氨酸受体 5(mGluR5)阻滞剂 MPEP 阻止了 JZL184 促进亚阈值 D1R+D2R 增强放电的能力,而 mGluR5 阻滞剂并不阻止 2-AG+D1R+D2R 对放电的增加,这表明 mGluR5 位于 2-AG 产生的上游。因此,我们的研究结果表明,NAc 核心区的内源性大麻素介导了多巴胺受体(DAR)对放电的增强作用,这可能为 NAc 核心区 D1Rs、D2Rs、CB1Rs 和 mGluR5s 在许多觅药行为中的核心作用提供了一种细胞机制。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验